193 related articles for article (PubMed ID: 1403647)
1. Clonal dominance: cause for a limited and failing immune response to HIV-1 infection and vaccination.
Kohler H; Goudsmit J; Nara P
J Acquir Immune Defic Syndr (1988); 1992; 5(11):1158-68. PubMed ID: 1403647
[TBL] [Abstract][Full Text] [Related]
2. Neutralization of HIV-1: a paradox of humoral proportions.
Nara PL; Garrity RR; Goudsmit J
FASEB J; 1991 Jul; 5(10):2437-55. PubMed ID: 1712328
[TBL] [Abstract][Full Text] [Related]
3. Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site.
Bogers WMJM; Barnett SW; Oostermeijer H; Nieuwenhuis IG; Beenhakker N; Mortier D; Mooij P; Koopman G; Remarque E; Martin G; Lai RP; Dey AK; Sun Y; Burke B; Ferrari G; Montefiori D; Martin L; Davis D; Srivastava I; Heeney JL
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701402
[TBL] [Abstract][Full Text] [Related]
4. Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response.
Zolla-Pazner S; Powell R; Yahyaei S; Williams C; Jiang X; Li W; Lu S; Wang S; Upadhyay C; Hioe CE; Totrov M; Kong X
J Virol; 2016 Dec; 90(24):10993-11006. PubMed ID: 27630234
[TBL] [Abstract][Full Text] [Related]
5. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.
Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ
Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745
[TBL] [Abstract][Full Text] [Related]
6. On the benefits of sin: can greater understanding of the 1F7-idiotypic repertoire freeze enhance HIV vaccine development?
Parsons MS; Muller S; Kohler H; Grant MD; Bernard NF
Hum Vaccin Immunother; 2013 Jul; 9(7):1532-8. PubMed ID: 23571168
[TBL] [Abstract][Full Text] [Related]
7. Intrastructural help: improving the HIV-1 envelope antibody response induced by virus-like particle vaccines.
Temchura V; Überla K
Curr Opin HIV AIDS; 2017 May; 12(3):272-277. PubMed ID: 28422791
[TBL] [Abstract][Full Text] [Related]
8. HIV-1-Specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galactosylceramide Blocking and Phagocytosis.
Wills S; Hwang KK; Liu P; Dennison SM; Tay MZ; Shen X; Pollara J; Lucas JT; Parks R; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Thomas R; Kim JH; Michael NL; Robb ML; McRaven M; Montefiori DC; Hope TJ; Liao HX; Moody MA; Ferrari G; Haynes BF; Alam SM; Bonsignori M; Tomaras GD
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321320
[TBL] [Abstract][Full Text] [Related]
9. Broadly Neutralizing Antibodies Against HIV: New Insights to Inform Vaccine Design.
Sadanand S; Suscovich TJ; Alter G
Annu Rev Med; 2016; 67():185-200. PubMed ID: 26565674
[TBL] [Abstract][Full Text] [Related]
10. Poly- and autoreactivity of HIV-1 bNAbs: implications for vaccine design.
Finney J; Kelsoe G
Retrovirology; 2018 Jul; 15(1):53. PubMed ID: 30055635
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034
[TBL] [Abstract][Full Text] [Related]
12. Serum antibodies to HIV-1 in recombinant vaccinia virus recipients boosted with purified recombinant gp160. NIAID AIDS Vaccine Clinical Trials Network.
Montefiori DC; Graham BS; Kliks S; Wright PF
J Clin Immunol; 1992 Nov; 12(6):429-39. PubMed ID: 1287035
[TBL] [Abstract][Full Text] [Related]
13. Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques.
Shen X; Bogers WM; Yates NL; Ferrari G; Dey AK; Williams WT; Jaeger FH; Wiehe K; Sawant S; Alam SM; LaBranche CC; Montefiori DC; Martin L; Srivastava I; Heeney J; Barnett SW; Tomaras GD
J Virol; 2017 Oct; 91(19):. PubMed ID: 28490585
[TBL] [Abstract][Full Text] [Related]
14. HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humans.
Williams KL; Cortez V; Dingens AS; Gach JS; Rainwater S; Weis JF; Chen X; Spearman P; Forthal DN; Overbaugh J
EBioMedicine; 2015 Oct; 2(10):1464-77. PubMed ID: 26629541
[TBL] [Abstract][Full Text] [Related]
15. Germinal center enhancement by extended antigen availability.
Cirelli KM; Crotty S
Curr Opin Immunol; 2017 Aug; 47():64-69. PubMed ID: 28738289
[TBL] [Abstract][Full Text] [Related]
16. Immunodominant B-cell clones responsive to an HIV-1 neutralization and cell fusion inhibition epitope in chimpanzee-to-chimpanzee passages of HTLV-IIIB and LAV-1.
Goudsmit J; Bakker M; Smit L
Res Virol; 1989; 140(5):405-18. PubMed ID: 2479965
[TBL] [Abstract][Full Text] [Related]
17. Site-directed primary in vitro immunization: production of HIV-1 neutralizing human monoclonal antibodies from lymphocytes obtained from seronegative donors.
Chin LT; Hinkula J; Levi M; Ohlin M; Wahren B; Borrebaeck CA
Immunology; 1994 Mar; 81(3):428-34. PubMed ID: 7515847
[TBL] [Abstract][Full Text] [Related]
18. Host controls of HIV broadly neutralizing antibody development.
Kelsoe G; Haynes BF
Immunol Rev; 2017 Jan; 275(1):79-88. PubMed ID: 28133807
[TBL] [Abstract][Full Text] [Related]
19. Modulation of Vaccine-Induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in Humans.
Pissani F; Schulte B; Eller MA; Schultz BT; Ratto-Kim S; Marovich M; Thongcharoen P; Sriplienchan S; Rerks-Ngarm S; Pitisuttithum P; Esser S; Alter G; Robb ML; Kim JH; Michael NL; Streeck H
J Virol; 2018 Dec; 92(23):. PubMed ID: 30209165
[TBL] [Abstract][Full Text] [Related]
20. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.
Patil S; Kumar R; Deshpande S; Samal S; Shrivastava T; Boliar S; Bansal M; Chaudhary NK; Srikrishnan AK; Murugavel KG; Solomon S; Simek M; Koff WC; Goyal R; Chakrabarti BK; Bhattacharya J
J Virol; 2016 Jan; 90(7):3446-57. PubMed ID: 26763999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
